OPKO Health, Inc. Depreciation
OPKO Health, Inc. (OPK) reported Depreciation of $3.40 million for the 3-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-28
- OPKO Health, Inc. depreciation for the quarter ending 2026-06-30 was $3.40M, a 5.56% decline year-over-year.
- OPKO Health, Inc. depreciation for the quarter ending 2026-03-31 was $3.20M, a 11.11% decline year-over-year.
- OPKO Health, Inc. depreciation for the quarter ending 2025-12-31 was $3.30M, a 10.81% decline year-over-year.
- OPKO Health, Inc. depreciation for the quarter ending 2025-09-30 was $3.20M, a 13.51% decline year-over-year.
- OPKO Health, Inc. depreciation for fiscal 2025 was $13.70M, a 12.18% decline from fiscal 2024.
- OPKO Health, Inc. depreciation for fiscal 2024 was $15.60M, a 19.17% decline from fiscal 2023.
- OPKO Health, Inc. depreciation for fiscal 2023 was $19.30M, a 7.66% decline from fiscal 2022.
- OPKO Health, Inc. depreciation for fiscal 2022 was $20.90M, a 26.41% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.40M 10-Q/A · filed 2026-08-28 | $6.70M 10-Q/A · filed 2026-08-28 | $9.90M derived: sum of 3 quarters · filed 2026-08-28 | $13.10M derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | $3.20M 10-Q/A · filed 2026-08-28 | $6.50M derived: sum of 2 quarters · filed 2026-08-28 | $9.70M derived: sum of 3 quarters · filed 2026-08-28 | $13.30M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.50M derived: sum of 2 quarters · filed 2026-02-26 | $10.10M derived: sum of 3 quarters · filed 2026-08-28 | $13.70M 10-K · filed 2026-02-26 |
| 2025-09-30 | $3.20M 10-Q · filed 2025-10-29 | $6.80M derived: sum of 2 quarters · filed 2026-08-28 | $10.40M 10-Q · filed 2025-10-29 | $14.10M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-06-30 | $3.60M 10-Q/A · filed 2026-08-28 | $7.20M 10-Q/A · filed 2026-08-28 | $10.90M derived: sum of 3 quarters · filed 2026-08-28 | $14.60M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-03-31 | $3.60M 10-Q/A · filed 2026-08-28 | $7.30M derived: sum of 2 quarters · filed 2026-08-28 | $11.00M derived: sum of 3 quarters · filed 2026-08-28 | $14.70M derived: sum of 4 quarters · filed 2026-08-28 |
| 2024-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.40M derived: sum of 2 quarters · filed 2026-02-26 | $11.10M derived: sum of 3 quarters · filed 2026-02-26 | $15.60M 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.70M 10-Q · filed 2025-10-29 | $7.40M derived: sum of 2 quarters · filed 2025-10-29 | $11.90M 10-Q · filed 2025-10-29 | $16.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $3.70M 10-Q · filed 2025-07-31 | $8.10M 10-Q · filed 2025-07-31 | $12.60M derived: sum of 3 quarters · filed 2026-02-26 | $17.40M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $4.40M 10-Q · filed 2025-05-01 | $8.90M derived: sum of 2 quarters · filed 2026-02-26 | $13.70M derived: sum of 3 quarters · filed 2026-02-26 | $18.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.30M derived: sum of 2 quarters · filed 2026-02-26 | $14.30M derived: sum of 3 quarters · filed 2026-02-26 | $19.30M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.80M 10-Q · filed 2024-11-07 | $9.80M derived: sum of 2 quarters · filed 2024-11-07 | $14.80M 10-Q · filed 2024-11-07 | $19.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $5.00M 10-Q · filed 2024-08-07 | $10.00M 10-Q · filed 2024-08-07 | $14.90M derived: sum of 3 quarters · filed 2025-03-03 | $19.90M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $5.00M 10-Q · filed 2024-05-07 | $9.90M derived: sum of 2 quarters · filed 2025-03-03 | $14.90M derived: sum of 3 quarters · filed 2025-03-03 | $20.10M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $9.90M derived: sum of 2 quarters · filed 2025-03-03 | $15.10M derived: sum of 3 quarters · filed 2025-03-03 | $20.90M 10-K · filed 2025-03-03 |
| 2022-09-30 | $5.00M 10-Q · filed 2023-11-06 | $10.20M derived: sum of 2 quarters · filed 2023-11-06 | $16.00M 10-Q · filed 2023-11-06 | $22.60M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | $5.20M 10-Q · filed 2023-08-03 | $11.00M 10-Q · filed 2023-08-03 | $17.60M derived: sum of 3 quarters · filed 2024-03-01 | $24.00M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | $5.80M 10-Q · filed 2023-05-03 | $12.40M derived: sum of 2 quarters · filed 2024-03-01 | $18.80M derived: sum of 3 quarters · filed 2024-03-01 | $26.80M derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $13.00M derived: sum of 2 quarters · filed 2024-03-01 | $21.00M derived: sum of 3 quarters · filed 2024-03-01 | $28.40M 10-K · filed 2024-03-01 |
| 2021-09-30 | $6.40M 10-Q · filed 2022-11-08 | $14.40M derived: sum of 2 quarters · filed 2022-11-08 | $21.80M 10-Q · filed 2022-11-08 | $29.30M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $8.00M 10-Q · filed 2022-08-04 | $15.40M 10-Q · filed 2022-08-04 | $22.90M derived: sum of 3 quarters · filed 2023-02-27 | $30.10M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $7.40M 10-Q · filed 2022-05-09 | $14.90M derived: sum of 2 quarters · filed 2023-02-27 | $22.10M derived: sum of 3 quarters · filed 2023-02-27 | $29.40M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $14.70M derived: sum of 2 quarters · filed 2023-02-27 | $22.00M derived: sum of 3 quarters · filed 2023-02-27 | $29.00M 10-K · filed 2023-02-27 |
| 2020-09-30 | $7.20M 10-Q · filed 2021-10-28 | $14.50M derived: sum of 2 quarters · filed 2021-10-28 | $21.50M 10-Q · filed 2021-10-28 | $28.70M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $7.30M 10-Q · filed 2021-07-29 | $14.40M 10-Q · filed 2021-07-29 | $21.50M derived: sum of 3 quarters · filed 2022-03-01 | $28.90M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $7.10M 10-Q · filed 2021-04-28 | $14.20M derived: sum of 2 quarters · filed 2022-03-01 | $21.60M derived: sum of 3 quarters · filed 2022-03-01 | $28.80M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $14.50M derived: sum of 2 quarters · filed 2022-03-01 | $21.70M derived: sum of 3 quarters · filed 2022-03-01 | $29.00M 10-K · filed 2022-03-01 |
| 2019-09-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $14.60M derived: sum of 2 quarters · filed 2020-10-29 | $21.90M 10-Q · filed 2020-10-29 | $29.30M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $14.50M 10-Q · filed 2020-07-31 | $21.90M derived: sum of 3 quarters · filed 2021-02-18 | $28.90M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | $7.30M 10-Q · filed 2020-05-06 | $14.70M derived: sum of 2 quarters · filed 2021-02-18 | $21.70M derived: sum of 3 quarters · filed 2021-02-18 | $29.20M derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $14.40M derived: sum of 2 quarters · filed 2021-02-18 | $21.90M derived: sum of 3 quarters · filed 2021-02-18 | $29.40M 10-K · filed 2021-02-18 |
| 2018-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $14.50M derived: sum of 2 quarters · filed 2019-11-05 | $22.00M 10-Q · filed 2019-11-05 | $29.90M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $15.00M 10-Q · filed 2019-08-07 | $22.90M derived: sum of 3 quarters · filed 2020-03-02 | $30.20M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $7.50M 10-Q · filed 2019-05-08 | $15.40M derived: sum of 2 quarters · filed 2020-03-02 | $22.70M derived: sum of 3 quarters · filed 2020-03-02 | $30.30M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $15.20M derived: sum of 2 quarters · filed 2020-03-02 | $22.80M derived: sum of 3 quarters · filed 2020-03-02 | $30.60M 10-K · filed 2020-03-02 |
| 2017-09-30 | $7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $14.90M derived: sum of 2 quarters · filed 2018-11-09 | $22.70M 10-Q · filed 2018-11-09 | $30.70M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $15.40M 10-Q · filed 2018-08-07 | $23.40M derived: sum of 3 quarters · filed 2019-03-01 | $31.10M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $7.80M 10-Q · filed 2018-05-08 | $15.80M derived: sum of 2 quarters · filed 2019-03-01 | $23.50M derived: sum of 3 quarters · filed 2019-03-01 | $32.40M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $15.70M derived: sum of 2 quarters · filed 2019-03-01 | $24.60M derived: sum of 3 quarters · filed 2019-03-01 | $33.30M 10-K · filed 2019-03-01 |
| 2016-09-30 | $7.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $16.60M derived: sum of 2 quarters · filed 2017-11-08 | $25.30M 10-Q · filed 2017-11-08 | $33.40M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-06-30 | $8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $17.60M 10-Q · filed 2017-08-08 | $25.70M derived: sum of 3 quarters · filed 2019-01-29 | $30.00M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-03-31 | $8.70M 10-Q · filed 2017-05-10 | $16.80M derived: sum of 2 quarters · filed 2019-01-29 | $21.10M derived: sum of 3 quarters · filed 2019-01-29 | $22.00M derived: sum of 4 quarters · filed 2019-01-29 |
| 2015-12-31 | $8.10M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $12.40M derived: sum of 2 quarters · filed 2019-01-29 | $13.30M derived: sum of 3 quarters · filed 2019-01-29 | $14.20M 8-K · filed 2019-01-29 |
| 2015-09-30 | $4.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $5.20M derived: sum of 2 quarters · filed 2016-11-07 | $6.10M 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $1.80M 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $900.00K 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $4.00M 10-K · filed 2017-03-01 | |||
| 2013-12-31 | $4.10M 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $1.80M 10-K · filed 2015-02-27 | |||
| 2011-12-31 | $400.00K 10-K · filed 2014-03-03 | |||
| 2010-12-31 | $200.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |